Mutual Funds Sahi Hai!
To avail the service, you will be redirected to loans.geojitcredits.com
Revenue from operations rose 2.08% to Rs 15,000 crore in Q4 FY25, compared with Rs 14,693 crore in Q4 FY24.
Profit before exceptional items and tax (PBIT) increased 3.46% to Rs 3,377 crore in Q4 FY25, compared with Rs 3,264 crore in Q4 FY24. Exceptional items stood at Rs 23 crore in Q4 FY25.
The company reported an underlying sales growth (USG) of 3% and an underlying volume growth (UVG) of 2%.
EBITDA stood at Rs 3,466 crore in Q4 FY25, up 0.90% compared with Rs 3,435 crore in Q4 FY24. EBITDA margin fell 30 bps to 23.1% in Q4 FY25 as against 23.4% in Q4 FY24.
During the quarter, home care USG was 3%, driven by mid-single-digit UVG. Beauty & Wellbeing turnover grew by 3% with low-single-digit UVG. Personal Care grew 3% with a low single-digit volume decline. Foods turnover declined 1% with low-single-digit price growth offset by volume decline.
On a full-year basis, the company’s standalone net profit jumped 5.24% to Rs 10,644 crore on a 1.84% rise in revenue from operations to Rs 60,680 crore in FY25 over FY24.
In its near to mid-term outlook, HUL anticipates a gradual improvement in growth, driven by ongoing portfolio transformation and a more favorable macroeconomic environment. The firm expects the first half of FY’26 to outperform the second half of FY’25. Assuming commodity prices remain stable, price growth is likely to remain in the low single digits, with a continued emphasis on volume-led, competitive expansion.
On the margins front, HUL foresees some moderation in gross margins as it maintains a strong price-value proposition for consumers. However, the company is actively stepping up investments to support portfolio changes in high-growth, innovation-driven categories. Despite these investments, EBITDA margins are expected to stay within a healthy range of 22–23%.
Rohit Jawa, CEO & managing director, commented, 'In FY'25, our turnover surpassed Rs 60,000 crore, with an underlying sales growth of 2% and an EPS growth of 5%. While absolute volume tonnage grew in mid-single digits, it was partially offset by a negative mix. We delivered a competitive performance, further strengthening our market leadership during the year.
This year marked a step up in our portfolio transformation with increased innovation in high-growth spaces, amplified investments in channels of the future, acquisition of Minimalist, divestment of Pureit, and the decision to demerge the ice cream business. Looking ahead, we anticipate demand conditions to gradually improve over the next fiscal year. We are committed to the strategic objective of unlocking a billion aspirations supported by our robust business fundamentals to continue winning competitively.'
Meanwhile, the company’s board has recommended a final dividend of Rs 24 for the financial year ended 31 March 2025 on equity shares of Rs 1 each.
HUL is in the FMCG business, comprising primarily of home care, beauty & personal care, and foods & refreshment segments. The company has manufacturing facilities across the country and sells primarily in India.
Pharma shares witnessed buying demand for fifth consecutive trading sessions.
Investors will also closely watch the market’s response to India’s latest diplomatic and economic measures against Pakistan, announced following Tuesday's terrorist attack in Pahalgam in Jammu & Kashmir, which claimed 26 lives. These measures include the suspension of the Indus Waters Treaty, shutting down the Wagah-Attari border, cancelling visas for Pakistanis, along with other measures.
At 11:25 IST, the barometer index, the S&P BSE Sensex shed 210.71 points or 0.25% to 79,912.93. The Nifty 50 index declined 63 points or 0.26% to 24,265.95.
In the broader market, the S&P BSE Mid-Cap index fell 0.11% and the S&P BSE Small-Cap index added 0.39%.
The market breadth was positive. On the BSE, 2,112 shares rose and 1,536 shares fell. A total of 194 shares were unchanged.
Economy:
On the macroeconomic front, the World Bank on Wednesday revised its growth outlook for India, trimming its forecast by 0.4 percentage points to 6.3% for the current fiscal year. The revision reflects rising global uncertainty, which the institution warned could dampen growth prospects across South Asia.
Buzzing Index:
The Nifty Pharma index jumped 1.17% to 21,993.85. The index rallied 5.36% in the five trading sessions.
Natco Pharma (up 11.21%), Divis Laboratories (up 5.22%), Zydus Lifesciences (up 2.03%), Lupin (up 1.97%), Ajanta Pharma (up 1.89%), Aurobindo Pharma (up 1.68%), J B Chemicals & Pharmaceuticals (up 1.29%), Dr Reddys Laboratories (up 1.27%), Glenmark Pharmaceuticals (up 1.22%) and Mankind Pharma (up 1.1%) advanced.
Stocks in Spotlight:
Supreme Petrochem advanced 1.08%. The petrochemical company reported 18.71% decline in standalone net profit to Rs 106.89 crore in Q4 FY25 as against Rs 131.50 crore posted in Q4 FY24. Total revenue from operations shed 1.52% YoY to Rs 1,539.02 crore in the quarter ended 31 March 2025.
Tata Consumer Products declined 1.76% after the company’s EBITDA margin narrowed by 250 bps to 13.6% in Q4 FY25 as against 16.1% in Q4 FY24, driven by higher input cost in India and international businesses.
The company reported a 52.06% jump in consolidated net profit to Rs 407.07 crore in Q4 FY25 as compared with Rs 267.71 crore in Q4 FY24. Revenue from operations jumped 17.35% to Rs 4,608.22 crore in Q4 FY25 as compared with Rs 3926.94 crore in Q4 FY24.
Hindustan Unilever (HUL) added 3.88% after the company reported a 3.61% jump in standalone net profit to Rs 2,493 crore in Q4 FY25, compared with Rs 2,406 crore in the corresponding quarter last year. Revenue from operations rose 2.08% to Rs 15,000 crore in Q4 FY25, compared with Rs 14,693 crore in Q4 FY24.
Global Market:
Asian market traded mixed on Thursday, following gains on Wall Street driven by renewed optimism over potential progress in U.S.-China trade relations.
In the latest development, China indicated a willingness to engage in trade talks with the United States. However, it emphasized that it would not participate in negotiations under continued threat of sanctions or tariffs from the U.S. administration. This dual stance contributed to cautious optimism among global investors.
In South Korea, advance estimates released Thursday showed that GDP contracted by 0.1% in the first quarter of 2025, signaling potential economic headwinds in the region.
On Wall Street, the three major indices closed higher overnight, supported by hopes that trade tensions may ease in the near term. Additionally, President Donald Trump signaled that he does not intend to remove Federal Reserve Chair Jerome Powell, a move that appeared to reassure financial markets.
At the close in NYSE, the Dow Jones Industrial Average rose 1.07%, while the S&P 500 index gained 1.67%, and the NASDAQ Composite index added 2.50%.
On Thursday, investors will look for quarterly earnings reports from Alphabet, Intel and PepsiCo. On the economic data front, durable gods orders and weekly jobless claims are also due.
For the full year,net profit rose 3.62% to Rs 10649.00 crore in the year ended March 2025 as against Rs 10277.00 crore during the previous year ended March 2024. Sales rose 2.17% to Rs 62288.00 crore in the year ended March 2025 as against Rs 60966.00 crore during the previous year ended March 2024.
Additionally, market volatility was heightened by the expiry of the monthly Nifty50 F&O contracts. Nifty closed below 24,250 mark after hitting day’s high of 24,347.85 in early trade. Realty, FMCG and consumer durable shares declined while pharma, metal and media shares advanced
As per provisional closing data, the barometer index, the S&P BSE Sensex declined 315.06 points or 0.39% to 79,801.43. The Nifty 50 index lost 82.25 points or 0.34% to 24,246.70.
The broader market underperformed the headline indices. The S&P BSE Mid-Cap index shed 0.16% and the S&P BSE Small-Cap index fell 0.01%.
The market breadth was negative. On the BSE, 1,926 shares rose and 2,011 shares fell. A total of 149 shares were unchanged.
The NSE's India VIX, a gauge of the market's expectation of volatility over the near term, jumped 1.81% to 16.25.
Buzzing index :
The Nifty FMCG index fell 1.06% to 56,887.55. The index jumped 2.44% in the past two trading session.
Hindustan Unilever (down 4.06%), United Breweries (down 2.99%), Varun Beverages (down 2.96%), Britannia Industries (down 1.68%), United Spirits (down 1.13%), Radico Khaitan (down 0.88%), Marico (down 0.55%), Godrej Consumer Products (down 0.28%), Nestle India (down 0.26%) and ITC (down 0.2%) declined.
On the other hand, Colgate-Palmolive (India) (up 1.39%),Dabur India (up 0.99%) and Tata Consumer Products (up 0.94%) advanced.
Hindustan Unilever (HUL) fell 4.06%. The company reported a 3.61% jump in standalone net profit to Rs 2,493 crore in Q4 FY25, compared with Rs 2,406 crore in the corresponding quarter last year. Revenue from operations rose 2.08% to Rs 15,000 crore in Q4 FY25, compared with Rs 14,693 crore in Q4 FY24. Meanwhile, the company’s board has recommended a final dividend of Rs 24 for the financial year ended 31 March 2025 on equity shares of Rs 1 each.
Nestle India shed 0.26%. The company standalone net profit declined 5.21% to Rs 885.41 crore in Q4 FY25, compared with Rs 934.17 crore posted in Q4 FY24. However, revenue from operations jumped 4.48% to Rs 5,503.9 crore in Q4 FY25 as against Rs 5,267.6 crore posted in Q4 FY24. Meanwhile, the company’s board recommended a final dividend of Rs 10 per equity share of the face value of Rs 1 each for the financial year 2024-25. The record date for the said dividend has been fixed as 4 July 2025.
Tata Consumer Products added 0.94%. The company reported a 52.06% jump in consolidated net profit to Rs 407.07 crore in Q4 FY25 as compared with Rs 267.71 crore in Q4 FY24. Revenue from operations jumped 17.35% to Rs 4,608.22 crore in Q4 FY25 as compared with Rs 3,926.94 crore in Q4 FY24.
Meanwhile, the company’s board has recommended a dividend of Rs. 8.25 per equity share of Rs. 1 each for FY25, which, if approved by the shareholders at the ensuing 62nd Annual General Meeting, will be paid on or after June 21, 2025.
Stocks In Spotlight:
Bajaj Housing Finance rose 0.30%. The company reported a 53.84% rise in standalone net profit to Rs 586.68 crore on a 25.62% increase in revenue from operations to Rs 2,507.96 crore in Q4 FY25, compared with Q4 FY24.
Dalmia Bharat gained 3.96% after the company’s consolidated net profit surged 38.09% to Rs 435 crore in Q4 FY25 as against Rs 315 crore posted in Q4 FY24. However, revenue from operations declined 5.01% YoY to Rs 4,091 crore posted in Q4 FY25.
Persistent Systems shed 0.45% after the company’s net profit advanced 6.1% to Rs 395.76 crore on a 5.87% increase in revenue to Rs 3,242.11 crore in Q4 FY25 over Q3 FY25.
Rallis India dropped 4.31% after the company’s standalone net loss widened to Rs 32 crore in Q4 FY25 as against a net loss of Rs 21 crore reported in Q4 FY24. Revenue from operations declined 1.37% YoY to Rs 430 crore in the quarter ended 31 March 2025. Meanwhile, the company’s board has recommended a dividend of Rs 2.50 per share for the financial year 2024-25. The dividend, if approved by the shareholders at the ensuing Annual General Meeting of the company, will be paid within five days of the AGM.
Vascon Engineers jumped 3.16% after the company received a letter of intent (LoI) worth Rs 85.43 crore from Yucca Promoters LLP, Pune, for the construction of a commercial building at Kalyani Nagar, Pune.
Black Box was locked in 10% upper circuit after the company announced that it had achieved order wins totaling Rs 1,550 crore in Q4 of the financial year 2024–25.
Thyrocare Technologies surged 9.45% after the healthcare service provider reported a 22.05% increase in consolidated net profit to Rs 21.70 crore on a 21.34% rise in revenue from operations to Rs 187.16 crore in Q4 FY25 over Q4 FY24.
Global Markets:
European shares declined on Thursday as investors are digesting earnings releases from Unilever, Banco Sabadell, Sanofi, Eni, BNP Paribas and Dassault Systemes.
Asian market ended mixed, following gains on Wall Street driven by renewed optimism over potential progress in U.S.-China trade relations.